Active Global Funds: Positioning Analysis, July 2025

333 Global Equity Funds, AUM $1.2tr Active Global Funds: Positioning Analysis, July 2025   Regional Trends The Magnificent 7: Active Global Fund Positioning Update Financials Exchanges: A Sector on the Rise Stock Analysis Alibaba Group Holding Ltd.: The Path to Redemption? Rheinmetall AG: Out of the Shadows Danaher Corporation: Reassessing the Investment Case Merck & Co., Inc.: Returning to the …

Continue Reading

Active GEM Funds: Positioning Analysis, July 2025

339 emerging market Funds, AUM $444bn Active GEM Funds: Positioning Analysis, July 2025   Regional Trends South Korea: Rebounding as Underweight Narrows Reversal in Progress: Indonesian Financials Lose Their Shine   Stock Analysis Alibaba Group Holdings: Back Towards the Highs Ambev SA: Establishing a Base AngloGold Ashanti Limited: Building on Momentum Zomato Ltd: Hitting a Plateau Turkcell Iletisim: Back on …

Continue Reading

Global Funds: Performance & Attribution Analysis, H1 2025

333 emerging market Funds, AUM $1.2tr Global Funds: Performance & Attribution Analysis, H1 2025   Active Global funds matched the benchmark, returning 10.23% on average in H1 2025, with 45.5% of funds outperforming. Value strategies led by a wide margin, with 80.7% outperforming and beating Aggressive Growth by nearly 6%. High Active funds dominated performance, with 39 of the top …

Continue Reading

UK Funds: Performance & Attribution, H1 2025

UK Fund Analysis UK Funds: Performance & Attribution, H1 2025 In this quarter’s UK performance & attribution report: Value leads again: 76% of Value funds outperformed in H1 2025, with average returns of 10.6%. Financials dominate: Major UK banks drove absolute returns across the peer group. Underweight drag: Names like Rolls-Royce, BAE, and HSBC hurt relative performance. For more analysis, data …

Continue Reading

UK Funds: Positioning Analysis, June 2025

UK Fund Analysis Active UK Funds: Positioning Analysis, June 2025 In this month’s UK positioning analysis: Sector Trends UK Energy: Concentrated, Under-Owned and Out Of Favour UK Homebuilding: Allocations Rebound as Sentiment Improves   Stock Analysis Land Securities Group PLC: Spiking to New Highs Aviva plc: Ownership Rebound after Decade-Long Slide Diploma PLC: Growth Managers Drive Record Ownership Ferguson Plc: …

Continue Reading

Europe Reasserted:  Consensus Builds as Europe Reclaims Ground from the U.S.

336 Global Equity Funds, AUM $1.1tr Active Global Funds: Positioning Analysis, June 2025 Europe Reasserted:  Consensus Builds as Europe Reclaims Ground from the U.S DM Europe remains the top regional overweight, with over 90% of global funds positioned above benchmark. Allocations have rebounded sharply from late-2024 lows, marking a renewed expression of long-term conviction. Positioning is broad-based, led by the …

Continue Reading

LATAM: The Conviction Overweight in a Benchmark-Driven World

340 emerging market Funds, AUM $420bn Active GEM Funds: Positioning Analysis, June 2025   LATAM:  The Conviction Overweight in a Benchmark-Driven World In this analysis, we review Latin America’s position within EM portfolios, where 85% of funds remain overweight relative to the MSCI EM benchmark. Allocations have eased from early-2024 highs but remain well above post-2020 lows. At the country …

Continue Reading

UK Funds: Positioning Analysis, May 2025

UK Fund Analysis Active UK Funds: Positioning Analysis, May 2025   In this month’s chart pack: Sector Trends Real Estate: From Underweight to Record Highs Health Care: Key Underweight Shows Signs of Strength Stock Analysis Spirax-Sarco Engineering: All-Time High BAE Systems plc: Momentum Reversal Shell PLC: Signs of Weakness Ashtead Group PLC:  The Exodus Continues Howden Joinery Group PLC: Pushing …

Continue Reading

Global Funds: Positioning Analysis, May 2025

332 Global Equity Funds, AUM $1.1tr Active Global Funds: Positioning Analysis, May 2025 Inside This Month’s Analysis Regional TrendsAustralia: Strategic Underweights & Ownership LowsIndustrials: Consensus Overweight Amid Growing Conviction   Stock AnalysisMercadoLibre Inc: Growth Funds Remain BullishDiageo plc: Diminishing InterestNVIDIA Corporation: Record Ownership Despite UnderweightSpotify Technology SA: Rising Up the ChartsWalt Disney Company: Confidence Returning Click on the below buttons …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley